Metastatic neuroendocrine lesions in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): a narrative review and case series
Endocrine Oncology · 01.01.2026 · 6 (1)
DOI: 10.1530/eo-25-0093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Oncology, online erschienen am 11.05.2026. Verfasst von David C Llewellyn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, London, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare entity characterised by the proliferation of neuroendocrine cells in the respiratory epithelium. DIPNECH is a pre-neoplastic condition that can progress to localised or metastatic neuroendocrine tumours (NETs). The understanding of DIPNECH remains limited, and although the European Neuroendocrine Society has recommendations for its management, there are currently no established guidelines.
Method
This study involves a case series of three patients with DIPNECH progressing to metastasis, as well as a narrative review of previous cases screened from Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica dataBASE (EMBASE), Cochrane Central Register of Controlled Trials (CENTRAL) and SCOPUS databases.
Results
In 40 documented cases of DIPNECH progression to metastasis, metastatic spread was more frequently observed in the thoracic lymph nodes, with a disproportionately high incidence of atypical carcinoid features on histological examination.
Conclusion
Patients with DIPNECH are a heterogeneous group, and based on current data, it is difficult to confidently predict which are more likely to experience metastases. We provide recommendations for surveillance for a range of possible outcomes, including if there is DIPNECH without metastases, if there are no metastases but particularly large lesions and when metastases are present. Patients with DIPNECH-associated atypical neuroendocrine tumours, TNM stage > IIA, R1 resection margins and/or involvement of the visceral pleura ought to be monitored most closely. There are currently insufficient data to make meaningful recommendations regarding treatment options to prevent metastases. Learning points
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, London, UK.
- Neuroendocrine Tumour Unit, King's Health Partners ENETS Centre of Excellence, London, UK.
- Faculty of Life Sciences and Medicine, King's College London, London, UK.
- Department of Histopathology, King's College Hospital NHS Foundation Trust, London, UK.
- Department of Radiology, King's College Hospital, NHS Foundation Trust, London, UK.
- King's College Hospital NHS Foundation Trust, London, UK.
ORCID-Profile: David C Llewellyn, Georgios K Dimitriadis, Rajaventhan Srirajaskanthan
Zitieren
APA
Llewellyn, D. C., Dolly, S., Ramage, J. K., Wasif, A., Kibriya, N., Dimitriadis, G. K., Llewellyn, A. M., & Srirajaskanthan, R. (2026). Metastatic neuroendocrine lesions in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): a narrative review and case series. Endocrine Oncology, 6(1). https://doi.org/10.1530/eo-25-0093
Vancouver
Llewellyn DC, Dolly S, Ramage JK, Wasif A, Kibriya N, Dimitriadis GK, et al. Metastatic neuroendocrine lesions in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): a narrative review and case series. Endocrine Oncology. 2026;6(1). doi:10.1530/eo-25-0093
BibTeX
@article{Llewellyn2026,
author = {Llewellyn, David C and Dolly, Saoirse and Ramage, John K and Wasif, Afsheen and Kibriya, Nabil and Dimitriadis, Georgios K and Llewellyn, Amy M and Srirajaskanthan, Rajaventhan},
title = {Metastatic neuroendocrine lesions in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): a narrative review and case series},
journal = {Endocrine Oncology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1530/eo-25-0093}
}
EUVIMED